Home/Filings/4/0001209191-21-051394
4//SEC Filing

Gesten Samuel J 4

Accession 0001209191-21-051394

CIK 0000718937other

Filed

Aug 12, 8:00 PM ET

Accepted

Aug 13, 4:22 PM ET

Size

20.5 KB

Accession

0001209191-21-051394

Insider Transaction Report

Form 4
Period: 2021-08-12
Gesten Samuel J
VP, General Counsel
Transactions
  • Exercise/Conversion

    Common Stock

    2021-08-12$16.15/sh+6,667$107,67249,250 total
  • Exercise/Conversion

    Common Stock

    2021-08-12$27.53/sh+7,156$197,00572,266 total
  • Sale

    Common Stock

    2021-08-12$134.71/sh29,682$3,998,46242,583 total
  • Exercise/Conversion

    Common Stock Options

    2021-08-126,6670 total
    Exercise: $16.15From: 2019-03-15Exp: 2028-03-14Common Stock (6,667 underlying)
  • Exercise/Conversion

    Common Stock Options

    2021-08-1211,3645,682 total
    Exercise: $35.98From: 2020-03-14Exp: 2029-03-13Common Stock (11,364 underlying)
  • Exercise/Conversion

    Common Stock

    2021-08-12$35.98/sh+11,364$408,87765,110 total
  • Exercise/Conversion

    Common Stock Options

    2021-08-124,4950 total
    Exercise: $29.80From: 2019-06-14Exp: 2028-06-13Common Stock (4,495 underlying)
  • Exercise/Conversion

    Common Stock Options

    2021-08-127,1568,946 total
    Exercise: $27.53From: 2021-03-20Exp: 2030-03-19Common Stock (7,156 underlying)
  • Exercise/Conversion

    Common Stock

    2021-08-12$29.80/sh+4,495$133,95153,746 total
Footnotes (3)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $131.58 to $137.35 inclusive.
  • [F2]The options granted become exercisable as follows: 1/3 on 3/14/2020 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/14/2022.
  • [F3]The options granted become exercisable as follows: 1/3 on 3/20/2021 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/20/2023.

Issuer

STAAR SURGICAL CO

CIK 0000718937

Entity typeother

Related Parties

1
  • filerCIK 0001496615

Filing Metadata

Form type
4
Filed
Aug 12, 8:00 PM ET
Accepted
Aug 13, 4:22 PM ET
Size
20.5 KB